FEIBA NF
FEIBA NF
Approved
DIN Number
02202581
Drug Class
Human
Market Date
Oct 27, 1997
Company
HC
takeda canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02202581
AIG Number0133136002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
B02BD03 FACTOR VIII INHIBITOR BYPASSING ACTIVITY
Product Specifications
Dosage FormPowder For Solution
,
Kit
Route of AdministrationIntravenous
AHFS Classification20:28.16
Health Canada Classification
ACTIVE INGREDIENTS (1)
ANTI-INHIBITOR COAGULANT COMPLEXActive
Strength: 1300 UNIT / VIAL
Monograph: ANTI-INHIBITOR COAGULANT COMPLEX